Company Filing History:
53 out of 123 
1 out of 2 
1 out of 832,912 Years Active: 2017-2025
Areas of Expertise:
Title: **Innovative Contributions of Stefanie Ann Ward Mortimer in Cancer Detection**
Introduction
Stefanie Ann Ward Mortimer, based in Morgan Hill, CA, is a prominent inventor in the field of cancer detection with an impressive portfolio of 46 patents. Her groundbreaking work focuses on developing methods and technologies that significantly enhance the early diagnosis of cancer, making it one of the critical advancements in medical science.
Latest Patents
Among her latest inventions, Mortimer has disclosed several methods for early cancer detection. These methods involve preparing cell-free nucleic acid molecules from asubject for sequencing and identifying cancer indicators. Additionally, she has developed systems and methods to detect rare mutations and copy number variations. This innovation entails extracting and isolating cell-free polynucleotide sequences from bodily fluids, followed by sequencing and applying bioinformatics tools to accurately identify genetic anomalies. Such advancements are invaluable in improving cancer profiling and diagnosis.
Career Highlights
Throughout her career, Mortimer has significantly contributed to the field, demonstrating exceptional expertise in molecular biology and oncology diagnostics. Her affiliation with Guardant Health, Inc. underscores the impact of her work in advancing cancer detection methodologies.
Collaborations
Mortimer has collaborated with notable professionals in the field, including Amirali Talasaz and Helmy A Eltoukhy. Their combined expertise in biotechnology and molecular diagnostics has led to innovative breakthroughs in understanding and detecting cancer at its early stages.
Conclusion
Stefanie Ann Ward Mortimer's contributions to cancer detection through her numerous patents highlight her role as a leading inventor in the medical field. Her innovative approaches not only pave the way for early diagnosis but also enhance the understanding of genetic mutations related to cancer, ultimately improving patient outcomes. Mortimer’s work exemplifies the profound influence of innovation in healthcare and the continual fight against cancer.